NCT01906567|Unknown
Loading search results
Sponsor study identifier
observational
90
1 country
2
Study Start
July 2013
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The purpose of this study, to investigate whether severity of preeclampsia is associated with altered levels of heavy metals (Cd, Hg, arsenic and Pb) in maternal blood, fetal blood, and maternal hair.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2013
Date type not reportedThis date has not been verified as actual or estimated.
July 5, 2013
Actual (reported)July 24, 2013
Actual (reported)September 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
increased levels of heavy metals in preeclamptic women
mercury, cadmium and lead levels in maternal blood and hair
6 months
Severe preeclampsia is defined as the presence of 1 of the following symptoms or signs in the presence of preeclampsia: • SBP of 160 mm Hg or higher or DBP of 110 mm Hg or higher on 2 occasions at least 6 hours apart • Proteinuria of more than 5 g in a 24-hour collection or more than 3+ on 2 random urine samples collected at least 4 hours apart • Pulmonary edema or cyanosis • Oliguria (\< 400 mL in 24 h) • Persistent headaches • Epigastric pain and/or impaired liver function • Thrombocytopenia • Oligohydramnios, decreased fetal growth, or placental abruption
Mild preeclampsia is defined as the presence of hypertension (BP ≥140/90 mm Hg) on 2 occasions, at least 6 hours apart, but without evidence of end-organ damage in the patient.
healthy pregnant women at term who not developed any complication of pregnancy
pregnant women with preeclampsia
Zekai Tahir Burak Maternity Teaching Hospital
Ankara, Ankara, 6400, Turkey (Türkiye)
Zekai Tahir Burak Education and Research Hospital
Ankara, Turkey (Türkiye)
maternal whole blood maternal hair umbilical whole blood
ayse kirbas, md
Zekai Tahir Burak Women's Health Research and Education Hospital
First Submitted
July 5, 2013
First Posted
July 24, 2013
Study Start
July 2013
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2013
Factors Associated With Blood Pressure Control Failure to Intravenous Labetalol in Severe Preeclampsia
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 6, 2013
Record last verified: 2013-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: